𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Down-regulation of vasoactive intestinal peptide and altered expression of its receptors in rat diabetic cardiomyopathy

✍ Scribed by Magdalena Chottová Dvoráková; Uwe Pfeil; Jitka Kuncová; Jitka Švíglerová; Giovanni Galvis; Gabriela Krasteva; Peter König; Veronika Grau; Jana Slavíková; Wolfgang Kummer

Publisher
Springer-Verlag
Year
2005
Tongue
English
Weight
504 KB
Volume
323
Category
Article
ISSN
0302-766X

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Expression and regulatory role of recept
Expression and regulatory role of receptors for vasoactive intestinal peptide in bone cells
✍ Pernilla Lundberg; Ulf H. Lerner 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 66 KB

## Abstract An intense network of nerve fibers can be demonstrated in skeletal tissues, not only in the periosteum but also within cortical bone, growth plate, and bone marrow. This neuro‐osteogenic network expresses a restricted number of signalling molecules, including neuropeptides, neurotransmi

Differential expression of vasoactive in
Differential expression of vasoactive intestinal peptide and its functional receptors in human osteoarthritic and rheumatoid synovial fibroblasts
✍ Yasmina Juarranz; Irene Gutiérrez-Cañas; Begoña Santiago; Mar Carrión; José L. P 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 328 KB 👁 2 views

## Abstract ## Objective Vasoactive intestinal peptide (VIP) has shown potent antiinflammatory effects in murine arthritis and ex vivo in human rheumatoid arthritis (RA) synovial cells. To investigate the potential endogenous participation of this system in the pathogenesis of RA, we analyzed the

Effects of Pygeum africanum extract (Tad
Effects of Pygeum africanum extract (Tadenan®) on vasoactive intestinal peptide receptors, G proteins, and adenylyl cyclase in rat ventral prostate
✍ Rosa M. Solano; M. Olga García-Fernández; Celia Clemente; Manuel Querol; Françoi 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 398 KB 👁 3 views

## Background: Tadenan (a pygeum africanum extract) is a drug used in the treatment of benign prostatic hyperplasia. its effects on prostate fibroblast proliferation and bladder function after partial outlet obstruction have been demonstrated in various pharmacological studies. however, its effects